This study is focused on a genetic condition called achondroplasia, which is the most common form of dwarfism. It affects how bones grow, particularly in the arms and legs, leading to a shorter stature and sometimes other health challenges. Researchers are testing a new medicine, SAR442501, to see if it can help improve the growth of bones in children and young people with this condition. This medicine is given as an injection under the skin, similar to how some people might take insulin.
This is a companion discussion topic for the original article at https://patient.info/research/trials/osteochondrodysplasia-2023-503677-37-00